{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:49:00Z","timestamp":1754110140545,"version":"3.37.3"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240025","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T17:43:07Z","timestamp":1601574187000},"page":"e0240025","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-0950","authenticated-orcid":true,"given":"Tarak","family":"Dhaouadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihen","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanene","family":"Gaied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Chamkhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Sfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rym","family":"Goucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fethi","family":"Ben Hamida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taieb","family":"Ben Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousr","family":"Gorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"issue":"3","key":"pone.0240025.ref001","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1681\/ASN.2015111262","article-title":"Toronto Glomerulonephritis Registry group. Membranous Nephropathy: Quantifying Remission Duration on Outcome","volume":"28","author":"DC Cattran","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"pone.0240025.ref002","first-page":"507","article-title":"Membranous nephropathy","volume":"9","author":"L Mercadal","year":"2013","journal-title":"Nephrol Ther"},{"issue":"1","key":"pone.0240025.ref003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"LH Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"pone.0240025.ref004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1423-0127-17-81","article-title":"Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan","volume":"17","author":"YH Liu","year":"2010","journal-title":"J Biomed Sci"},{"key":"pone.0240025.ref005","doi-asserted-by":"crossref","first-page":"c253","DOI":"10.1159\/000320194","article-title":"Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy","volume":"117","author":"S Kim","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"7","key":"pone.0240025.ref006","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"HC Stanescu","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0240025.ref007","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"AE Van de Logt","year":"2019","journal-title":"Kidney Int"},{"issue":"7","key":"pone.0240025.ref008","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"E Hoxha","year":"2012","journal-title":"Kidney Int"},{"key":"pone.0240025.ref009","first-page":"186","article-title":"Clinical Practice Guidelines for Glomerulonephritis. Idiopathic membranous nephropathy","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"pone.0240025.ref010","first-page":"40","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"1997","author":"MC Hochberg","year":"1725","journal-title":"Arthritis Rheum"},{"issue":"2","key":"pone.0240025.ref011","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"JJ Weening","year":"2004","journal-title":"Kidney Int"},{"key":"pone.0240025.ref012","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/nar\/16.3.1215","article-title":"A sampling salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"SA Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"pone.0240025.ref013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","article-title":"Primary membranous nephropathy: comprehensive review and historical perspective","volume":"95","author":"KC Keri","year":"2019","journal-title":"Postgrad Med J"},{"issue":"12","key":"pone.0240025.ref014","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1681\/ASN.2015010091","article-title":"Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy","volume":"26","author":"A Thompson","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"pone.0240025.ref015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0961203319828521","article-title":"Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis","volume":"28","author":"E Garcia-Vives","year":"2019","journal-title":"Lupus"},{"issue":"2","key":"pone.0240025.ref016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40620-017-0451-5","article-title":"Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases","volume":"31","author":"A Radice","year":"2018","journal-title":"J Nephrol"},{"key":"pone.0240025.ref017","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"W Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"pone.0240025.ref018","first-page":"109","article-title":"Anti-PLA2R antibodies in membranous nephropathy: ready for routine clinical practice?","volume":"70","author":"JM Hofstra","year":"2012","journal-title":"Neth J Med"},{"key":"pone.0240025.ref019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fmed.2018.00101","article-title":"Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis","volume":"5","author":"W Li","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"pone.0240025.ref020","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40620-018-0533-z","article-title":"Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy","volume":"31","author":"M Tampoia","year":"2018","journal-title":"J Nephrol"},{"key":"pone.0240025.ref021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cca.2017.11.006","article-title":"Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients","volume":"476","author":"Y Liu","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"11","key":"pone.0240025.ref022","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ndt\/gfv228","article-title":"Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy","volume":"30","author":"E Hoxha","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"pone.0240025.ref023","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12882-019-1544-2","article-title":"Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis","volume":"20","author":"Y Liang","year":"2019","journal-title":"BMC Nephrol"},{"issue":"9","key":"pone.0240025.ref024","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s11255-019-02147-9","article-title":"Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis","volume":"51","author":"W Li","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"pone.0240025.ref025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"D Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"pone.0240025.ref026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/IJNRD.S176665","article-title":"Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults","volume":"11","author":"X Wu","year":"2018","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"2","key":"pone.0240025.ref027","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1681\/ASN.2017070734","article-title":"Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy","volume":"29","author":"B Seitz-Polski","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pone.0240025.ref028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ekir.2017.09.001","article-title":"Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy","volume":"3","author":"R Ramachandran","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"4","key":"pone.0240025.ref029","first-page":"491","article-title":"Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus","volume":"34","author":"A Segarra-Medrano","year":"2014","journal-title":"Nefrologia"},{"issue":"8","key":"pone.0240025.ref030","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1681\/ASN.2012080771","article-title":"Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy","volume":"24","author":"J Lv","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"pone.0240025.ref031","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2215\/CJN.05310513","article-title":"HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy","volume":"9","author":"G Bullich","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"pone.0240025.ref032","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ndt\/gfv399","article-title":"PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians","volume":"31","author":"R Ramachandran","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0240025.ref033","first-page":"1","article-title":"Association of SNPs in PLA2R1 with idiopathic and secondary membranous nephropathy in two Chinese cohorts","volume":"2019","author":"CX Tian","journal-title":"Br J Biomed Sci"},{"issue":"2","key":"pone.0240025.ref034","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10157-017-1471-0","article-title":"Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy","volume":"22","author":"H Kaga","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"pone.0240025.ref035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/VHRM.S160883","article-title":"Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy","volume":"14","author":"L Liu","year":"2018","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"pone.0240025.ref036","doi-asserted-by":"crossref","first-page":"e0158154","DOI":"10.1371\/journal.pone.0158154","article-title":"Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy","volume":"11","author":"K Hihara","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"pone.0240025.ref037","doi-asserted-by":"crossref","first-page":"e0173201","DOI":"10.1371\/journal.pone.0173201","article-title":"Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years","volume":"12","author":"F Pourcine","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0240025.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000453675","article-title":"Immunohistochemical Glomerular Expression of Phospholipase A2 Receptor in Primary and Secondary Membranous Nephropathy: A Retrospective Study in an Indian Cohort with Clinicopathological Correlations","volume":"7","author":"S Roy","year":"2017","journal-title":"Nephron Extra"},{"issue":"11","key":"pone.0240025.ref039","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/imj.13233","article-title":"Detection and clinical significance of glomerular M-type phospholipase A2 receptor in patients with idiopathic membranous nephropathy","volume":"46","author":"H Liu","year":"2016","journal-title":"Intern Med J"},{"issue":"8","key":"pone.0240025.ref040","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4103\/0366-6999.204096","article-title":"Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy","volume":"130","author":"NX Xu","year":"2017","journal-title":"Chin Med J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T17:43:51Z","timestamp":1601574231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240025"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Remuzzi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240025","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}